Skip NavigationSkip to Content
Return Return to Search Results

Silencing the formylpeptide receptor FPR by short-interfering RNA

  1. Author:
    Le, Y. Y.
    Iribarren, P.
    Zhou, Y.
    Gong, W. H.
    Hu, J. Y.
    Zhang, X.
    Wang, J. M.

  2. Author Address

    NCI, Ctr Canc Res, Mol Immunoregulat Lab, Frederick, MD 21702 USA. NCI, Ctr Canc Res, Expt Immunol Lab, Frederick, MD 21702 USA. NCI, SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA. Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China. Cent So Univ, Xiang Ya Med Sch, Inst Canc Res, Changsha, Peoples R China Wang, JM, NCI, Ctr Canc Res, Mol Immunoregulat Lab, Bldg 560,Room 31-40, Frederick, MD 21702 USA
    1. Year: 2004
    2. Date: OCT
  2. Journal: Molecular Pharmacology
    1. 66
    2. 4
    3. Pages: 1022-1028
  4. Type of Article: Article
  1. Abstract:

    A double-stranded short-interfering RNA ( siRNA) was designed to attenuate the expression and function of the formylpeptide receptor FPR, a G protein-coupled receptor mediating migration and activation of phagocytic leukocytes in response to bacterial chemotactic formylpeptides. Retrovirus-based constructs were generated to introduce FPR-siRNA into a rat leukemia cell line transfected to overexpress FPR. Cells infected with FPR-siRNAT28, which targets the nucleotides 926 to 944 of FPR mRNA corresponding to the third extracellular loop of the putative receptor protein, showed significantly reduced expression of FPR mRNA and protein, in association with impaired calcium mobilization and chemotactic responses to peptide agonists. Direct transduction of synthetic FPR-siRNAT28 into human macrophages also inhibited the expression of FPR and abrogated cell chemotaxis and the release of superoxide anions induced by the bacterial formylpeptide. FPR-siRNA additionally abrogated the expression and function of FPR in a human malignant glioma cell line. Our study demonstrates successful application of siRNA to silence a G protein-coupled chemoattractant receptor involved in inflammation and suggests the potential to use this approach in studies of receptor regulation and prevention of undesirable side effects associated with FPR activation

    See More

  1. Keywords:

External Sources

  1. View record in Web of Science®
  2. WOS: 000223997400029

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel